Investigation of the structural requirement for inhibiting HIV integrase: QSAR study
By: Nigus Dessalew
Open Access
|Mar 2009References
- D. Finzi, J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant and R. F. Siliciano, Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1,(1999) 512-517; DOI: 10.1038/8394.
- S. G. Deeks, M. Smith, M. Holodniy and J. O. Kahn, HIV-1 protease inhibitors. A review for clinicians,(1997) 145-153; DOI: 10.1001/jama.277.2.145.
- J. Martinez-Picado, M. P. DePasquale, N. Kartsonis, G. J. Hanna, J. Wong, D. Finzi, E. Rosenberg, H. F. Günthard, L. Sutton, A. Savara, C.J. Petropoulos, N. Hellmann, B. D. Walker, D. Richman, R. Siliciano and R. T. D'Aquila, Antiretroviral resistance during successful therapy of HIV type 1 infection,(2000) 10948-10953.
- C. L. Kuiken, B. Foley, B. Hahn, P. A. Marx, F. McCutchan, J. Mellors, J. Mullins, S. Wolinsky and B. Korber,, Theoretical Biology and Biophysics Group, Los Alamos National Labatory: Los Alamos, Wiley, New York 2000.
- P. O. Brown,, in(Eds. J. M. Coffin, S. H. Hughes and H. E. Varmus), Cold Spring Harbor Laboratry Press, Cold Spring Harbor, New York 1997, pp. 161-203.
- E. Asante-Appiah and A. M. Skalka, HIV-1 integrase: structural organization, conformational changes, and catalysis,(1999) 351-369; DOI: 10.1016/S0065-3527(08)60306-1.
- N. J. Anthony, HIV-1 integrase: a target for new AIDS chemotherapeutics,(2004) 979-990; DOI: 10.2174/1568026043388448.
- T. K Chiu and D. R. Davies, Structure and function of HIV-1 integrase,(2004) 965-977; DOI: 10.2174/1568026043388547.
- A. Kovatcheva, G. Buchbauer, A. Golbraikh and P. Wolschann, QSAR modeling of alpha-campholenic derivatives with sandalwood odor,(2003) 259-266; DOI: 10.1021/ci020296n.
- N. Dessalew and P. V. Bharatam, 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: An insight into the criteria for selectivity,(2007) 1014-1027; DOI: 10.1016/j.ejmech.2007.01.010.
- N. Dessalew, D. S. Patel and P. V Bharatam, 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3b inhibitors,(2007) 885-895; DOI: 10.1016/j.jmgm.2006.08.009.
- N. Dessalew, P. V. Bharatam and S. K. Singh, 3D-QSAR CoMFA study on aminothiazole derivatives as cyclin-dependent kinase 2 inhibitors,(2007) 85-91; DOI: 10.1002/qsar.200630032.
- N. Dessalew, QSAR study on aminophenylbenzamides and acrylamides as histone deacetylase inhibitors: An insight into the structural basis of antiproliferative activity,(2008), 449-460; DOI: 10.1007/s00044-007-9085-9.
- D. C. Meadows, T. B. Mathews, T. W. North, M. J. Hadd, C. L. Kuo, N. Neamati and J. Gervay-Hague, Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors,(2005) 4526-4534; DOI: 10.1021/jm049171v.
- J. A. Grobler, K. Stillmock, B. Hu, M. Witmer, P. Felock, A. S. Espeseth, A. Wolfe, M. Egbertson, M. Bourgeois, J. Melamed, J. S. Wai, S. Young, J. Vacca and D. J. Hazuda, Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes,(2002) 6661-6666; DOI: 10.1073/pnas.092056199.
- W. G. Verschueren, I. Dierynck, I. E. Katie, L. Hu, M. J. Paul, G. Boonants, M. E. Pille, F. D. Frits, K. Hertogs, L. N. Dominique, G. Surleraux, B. T. Piet and P. Wigerinck, Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 Integrase,(2005) 1930-1940; DOI: 10.1021/jm049559q.
- A. Verloop, W. Hoogenstraaten and J. Tipker, Development and Application of new Steric Substituent Parameters,(Ed. E. J. Ariens), Academic Press, New York 1976, pp. 165-207.
- A. Verloop and J. Tipker, Use of linear free energy related and other parameters in the study of fungicidal selectivity,(1976) 379-390.
- Verloop and J. Tipker, A comparative study of new parameters in drug design, in(Ed. J. A. Keverling Buisman), Elsevier, Amsterdam 1977, pp. 63-81.
Language: English, Croatian
Page range: 31 - 43
Published on: Mar 20, 2009
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2009 Nigus Dessalew, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.